EN
HI
Marksans Pharma Share price
MARKSANS
236.25
8.75 (3.85%)NSE
BSE
Last updated on 30 Jul, 2025 | 15:41 IST
BUYSELL
Today's High
241.00
Today's Low
227.75
52 Week Low
171.00
52 Week High
358.70
The current prices are delayed, login to your account for live prices
LoginMarksans Pharma Chart
Marksans Pharma Share Key Metrics
Volume
33.72 L
Market Cap
10708.94 CR
LTQ@LTP
1@236.25
ATP
233.97
Var Margin
23.63 %
Circuit Range
182-273
Delivery %
53.45 %
Value
78.90 CR
ASM/GSM
No
Market Lot
1
Marksans Pharma Corporate Actions
| Date | Agenda | |
|---|---|---|
| 2025-08-12 | Quarterly Results | |
| 2025-05-19 | Audited Results & Final Dividend | |
| 2025-02-11 | Quarterly Results | |
| Date | Record Date | ||
|---|---|---|---|
 | |||
Marksans Pharma News
Marksans Pharma stock skyrockets 13% on strong all-round Q1 earnings show
Aug 14 2024 12:31:54
Read More
About Marksans Pharma
NSE : 10579
BSE : 524404
ISIN : INE750C01026
Marksans Pharma Management
| Name | Position |
|---|---|
| Mr. Mark Saldanha | Chairman & Managing Director |
| Mrs. Sandra Saldanha | Whole Time Director |
| Mr. Varddhman V Jain | Whole Time Director |
| Dr. Sunny Sharma | Non Executive Director |
| Mr. Srinivas Mishra | Independent Director |
Marksans Pharma Similar Stocks
Alivus Life Sciences Ltd.
1050.30
33.70 (3.31%)
Vijaya Diagnostic Centre Ltd.
1093.50
-26.20 (2.34%)
Sanofi Consumer Healthcare India Ltd.
4959.00
-42.00 (0.84%)
Granules India Ltd.
492.15
1.70 (0.35%)
Medplus Health Services Ltd.
934.45
23.35 (2.56%)
Metropolis Healthcare Ltd.
2020.10
69.80 (3.58%)
Acutaas Chemicals Ltd.
1220.30
53.20 (4.56%)
Jupiter Life Line Hospitals Ltd.
1439.90
0.70 (0.05%)
Shilpa Medicare Ltd.
919.15
20.10 (2.24%)
Marksans Pharma FAQs
The Buying Price of Marksans Pharma share is 236.25 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Marksans Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Marksans Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Marksans Pharma shares is 27.1. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Marksans Pharma shares is 4.18. Useful to assess the stock's value relative to its book value.
To assess Marksans Pharma’s valuation compare Sector P/E, P/B which are 35.89 & 3.9 with sector averages, along with growth rates and financial metrics.
The Market Cap of Marksans Pharma is 10708.94 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Marksans Pharma share price is 358.70 & 171.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.